Hanna Cancer Associates provides state-of-the-art treatment for cancer and blood disorders. We believe that each patient is unique and reacts to a disease in his or her own way. The goal of the practice is to identify and provide the right treatment for each patient and to do so compassionately. This is what we have been known for over the past 30 years.
Identifying the right treatment requires experience and expertise with the newest treatments available. As a Professor in the Department of Medicine, and Chief of the Hematology/Oncology Division at the University of Tennessee Medical Center, Dr. Hanna teaches medical students and residents about continuing developments and progress in the field of medicine. In addition, he is the principal investigator of 90 percent of all cancer clinical trials conducted at the Medical Center.